- Home
- FENC vs ENX Comparison
FENC vs ENX Comparison
Compare FENC & ENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- ENX
- Stock Information
- Founded
- FENC 1996
- ENX 2002
- Country
- FENC United States
- ENX United States
- Employees
- FENC N/A
- ENX N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- ENX Finance/Investors Services
- Sector
- FENC Health Care
- ENX Finance
- Exchange
- FENC Nasdaq
- ENX Nasdaq
- Market Cap
- FENC 181.7M
- ENX 170.1M
- IPO Year
- FENC 2001
- ENX N/A
- Fundamental
- Price
- FENC $3.99
- ENX $9.73
- Analyst Decision
- FENC Strong Buy
- ENX
- Analyst Count
- FENC 2
- ENX 0
- Target Price
- FENC $14.00
- ENX N/A
- AVG Volume (30 Days)
- FENC 116.0K
- ENX 25.4K
- Earning Date
- FENC 11-07-2024
- ENX 01-01-0001
- Dividend Yield
- FENC N/A
- ENX 3.94%
- EPS Growth
- FENC N/A
- ENX N/A
- EPS
- FENC N/A
- ENX 0.16
- Revenue
- FENC $49,348,000.00
- ENX N/A
- Revenue This Year
- FENC $116.50
- ENX N/A
- Revenue Next Year
- FENC $17.49
- ENX N/A
- P/E Ratio
- FENC N/A
- ENX $61.00
- Revenue Growth
- FENC 278.09
- ENX N/A
- 52 Week Low
- FENC $3.97
- ENX $7.84
- 52 Week High
- FENC $11.92
- ENX $10.07
- Technical
- Relative Strength Index (RSI)
- FENC 38.47
- ENX 55.02
- Support Level
- FENC $3.99
- ENX $9.60
- Resistance Level
- FENC $4.57
- ENX $9.70
- Average True Range (ATR)
- FENC 0.31
- ENX 0.12
- MACD
- FENC -0.02
- ENX 0.03
- Stochastic Oscillator
- FENC 2.33
- ENX 93.94
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.